Expression and characterization of N-terminal domain of Epstein-Barr virus latent membrane protein 2A in Escherichia coli

Protein Expression and Purification

Volumn 41, Issue 1, 2005, Pages 9-17

  Park, Sung Jean ^a   Seo, Min Duk ^a   Lee, Suk Kyeong ^b   Ikeda, Masato ^c   Longnecker, Richard ^c   Lee, Bong Jin ^a  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

EBV; Intein; LMP2A; NMR; Proteolysis; WW domain

Indexed keywords

EID: 15744369464     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.07.006     Document Type: Article

References (36)

1. M. Ikeda, A. Ikeda, L.C. Longan, and R. Longnecker The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases Virology 268 2000 178 191
2. C.G. Panousis, and D.T. Rowe Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase J. Virol. 71 1997 4752 4760
3. G. Winberg, L. Matskova, F. Chen, P. Plant, D. Rotin, G. Gish, R. Ingham, I. Ernberg, and T. Pawson Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases Mol. Cell. Biol. 20 2000 8526 8535
4. B. Roizman, R.J. Whitley, and C. Lopez The human herpesviruses 1994 Raven Press New York
5. C.L. Miller, A.L. Burkhardt, J.H. Lee, B. Stealey, R. Longnecker, J.B. Bolen, and E. Kieff Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases Immunity 2 1995 155 166
6. C.L. Miller, J.H. Lee, E. Kieff, A.L. Burkhardt, J.B. Bolen, and R. Longnecker Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction Infect. Agents Dis. 3 1994 128 136
7. C.L. Miller, J.H. Lee, E. Kieff, and R. Longnecker An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking Proc. Natl. Acad. Sci. USA 91 1994 772 776
8. C.L. Miller, R. Longnecker, and E. Kieff Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes J. Virol. 67 1993 3087 3094
9. R.G. Caldwell, J.B. Wilson, S.J. Anderson, and R. Longnecker Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals Immunity 9 1998 405 411
10. A.L. DeFranco The complexity of signaling pathways activated by the BCR Curr. Opin. Immunol. 9 1997 296 308
11. S. Fruehling, and R. Longnecker The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction Virology 235 1997 241 251
12. S. Fruehling, R. Swart, K.M. Dolwick, E. Kremmer, and R. Longnecker Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency J. Virol. 72 1998 7796 7806
13. R. Longnecker, and E. Kieff A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1 J. Virol. 64 1990 2319 2326
14. R. Longnecker, B. Druker, T.M. Roberts, and E. Kieff An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase J. Virol. 65 1991 3681 3692
15. F. Scholle, R. Longnecker, and N. Raab-Traub Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells Virology 291 2001 208 214
16. M. Ikeda, A. Ikeda, and R. Longnecker PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins J. Virol. 75 2001 5711 5718
17. L. Matskova, I. Ernberg, T. Pawson, and G. Winberg C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal J. Virol. 75 2001 10941 10949
18. L in micelles Biochemistry 39 2000 11024 11033
19. U. Matthey, G. Kaim, D. Braun, K. Wüthrich, and P. Dimroth NMR studies of subunit c of the ATP synthase from Propionigenium modestum in dodecylsulphate micelles Eur. J. Biochem. 261 1999 459 467
20. G.D. Henry, and B.D. Sykes Assignment of amide 1H and 15N NMR resonances in detergent-solubilized M13 coat protein: a model for the coat protein dimer Biochemistry 31 1992 5284 5297
21. G.G. Kochendoerfer, D. Salom, J.D. Lear, R. Wilk-Orescan, S.B.H. Kent, and W.F. DeGrado Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly Biochemistry 38 1999 11905 11913
22. K-H. Ruan, D. Li, J. Ji, Y-Z. Lin, and X. Gao Structural characterization and topology of the second potential membrane anchor region in the thromboxane A2 synthase amino-terminal domain Biochemistry 37 1998 822 830
23. J. Brosius Toxicity of an overproduced foreign gene product in Escherichia coli and its use in plasmid vectors for the selection of transcription terminators Gene 27 1984 161 172
24. W.P. Sisk, J.D. Bradley, D. Kingsley, and T.A. Patterson Deletion of hydrophobic domains of viral glycoproteins increases the level of their production in Escherichia coli Gene 112 1992 157 162
25. S.J. Park, S.K. Lee, and B.J. Lee Effect of tandem rare codon substitution and vector-host combinations on the expression of the EBV gp110 C-terminal domain in Escherichia coli Protein Expr. Purif. 24 2002 470 480
26. R.J. Jenny, K.G. Mann, and R.L. Lundblad A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa Protein Expr. Purif. 31 2003 1 11
27. J.D. Lonsdale-Eccles, D.H. Hogg, and D.T. Elmore The hydrolysis of chemically modified proteins by factor Xa and thrombin Biochim. Biophys. Acta 612 1980 401 409
28. J.Y. Chang Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate Eur. J. Biochem. 151 1985 217 224
29. J.Y. Chang, S.S. Alkan, N. Hilschmann, and D.G. Braun Thrombin specificity. Selective cleavage of antibody light chains at the joints of variable with joining regions and joining with constant regions Eur. J. Biochem. 151 1985 225 230
30. M.J. Raftery, L. Collinson, and C.L. Geczy Overexpression, oxidative refolding, and zinc binding of recombinant forms of murine S100 protein MRP14(S100A9) Protein Expr. Purif. 15 1999 228 235
31. T. Takagi, and R.F. Doolittle Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin Biochemistry 13 1974 750 756
32. M. Honda, E.A. Brown, and S.M. Lemon Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA RNA 10 1996 955 968
33. H. Lee, S.E. Bingham, and A.N. Webber Function of 3′ non-coding sequences and stop codon usage in expression of the chloroplast psaB gene in Chlamydomonas reinhardtii Plant Mol. Biol. 31 1996 337 354
34. L.H. Chen, S.A. Emory, A.L. Bricker, P. Bouvet, and J.G. Belasco Structure and function of a bacterial mRNA stabilizer: analysis of the 5′ untranslated region of ompA mRNA J. Bacteriol. 173 1991 4578 4586
35. T.R. Fuerst, and B. Moss Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5′ untranslated leader J. Mol. Biol. 206 1989 333 348
36. P.E. Wright, and H.J. Dyson Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm J. Mol. Biol. 293 1999 321 331